Terns Pharmaceuticals, Inc.
TERN
Revenue
0.00
▼-1.00M▼-100.00%
12 Months ChangeAssets
301.65M
▼-18.76M▼-5.86%
3 Months ChangeLiabilities
17.59M
▲2.40M▲15.80%
3 Months ChangeFree Cash Flow
-24.44M
▼-1.61M▼-7.07%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-01-22
Form 8-K
ID: 0001193125-26-019426
2026-01-09
Form 8-K
ID: 0001193125-26-008907
2025-12-11
Form 8-K
ID: 0001193125-25-315065
2025-12-08
Form 8-K
ID: 0001193125-25-311202
2025-11-10
Form 10-Q
ID: 0001193125-25-274367
2025-11-10
Form 8-K
ID: 0001193125-25-274282
2025-11-03
Form 8-K
ID: 0001193125-25-261798
2025-10-22
Form 8-K
ID: 0001193125-25-245404
2025-08-05
Form 10-Q
ID: 0000950170-25-103124
2025-08-05
Form 8-K
ID: 0000950170-25-103071